tiprankstipranks
Trending News
More News >
Terragen Holdings Ltd (AU:TGH)
:TGH
Australian Market
Advertisement

Terragen Holdings Ltd (TGH) AI Stock Analysis

Compare
1 Followers

Top Page

AU:TGH

Terragen Holdings Ltd

(Sydney:TGH)

Rating:40Underperform
Price Target:
AU$0.00
▼(-100.00% Downside)
The overall stock score is heavily impacted by weak financial performance characterized by declining revenues and negative cash flow. The technical analysis indicates a bearish trend, and poor valuation metrics further contribute to the low score. Immediate focus on improving operational efficiencies and financial sustainability is crucial.

Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)

Terragen Holdings Ltd Business Overview & Revenue Model

Company DescriptionTerragen Holdings Ltd (TGH) is a diversified company operating primarily in the renewable energy and environmental solutions sectors. The company focuses on providing innovative and sustainable energy solutions, including wind, solar, and hydroelectric power systems. TGH is dedicated to advancing environmental sustainability through technology-driven products and services.
How the Company Makes MoneyTerragen Holdings Ltd generates revenue through various streams primarily centered around its renewable energy operations. The company earns money by selling generated electricity from its renewable energy facilities to utility companies and end-users. Additionally, TGH engages in long-term power purchase agreements (PPAs) which provide a stable and predictable income. The company may also receive government incentives and subsidies designed to support renewable energy projects. Strategic partnerships with technology firms and environmental organizations further enhance its revenue potential by allowing for joint ventures and shared investments in clean energy initiatives.

Terragen Holdings Ltd Financial Statement Overview

Summary
Terragen Holdings Ltd faces significant challenges with declining revenues and persistent losses. Despite a strong equity position, negative cash flows and operational inefficiencies pose risks to sustainability.
Income Statement
35
Negative
Terragen Holdings Ltd has seen declining revenue from previous periods, with a TTM revenue of $1.85M compared to $2.14M annually. The gross profit margin is strong at 74.15% for TTM, yet EBIT and EBITDA margins are negative, indicating operational inefficiencies. The company faces consistent net losses, affecting the net profit margin negatively.
Balance Sheet
55
Neutral
The company's balance sheet shows a strong equity position with an equity ratio of 74.83% in TTM, which indicates financial stability and lower leverage. However, the debt-to-equity ratio is low at 0.08, suggesting low usage of debt financing. The high stockholders' equity offers a cushion against liabilities.
Cash Flow
40
Negative
Terragen Holdings Ltd has a concerning cash flow position, with negative operating and free cash flows, indicating cash outflows exceeding inflows. The operating cash flow to net income ratio is negative, highlighting inefficient cash generation from operations. The free cash flow growth rate is also negative, reflecting ongoing cash burn.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue2.14M3.28M2.89M3.65M1.53M
Gross Profit2.06M3.21M2.62M3.19M1.09M
EBITDA-3.50M-3.46M-5.67M-6.13M-4.97M
Net Income-3.01M-3.23M-5.41M-6.10M-4.93M
Balance Sheet
Total Assets6.95M6.35M9.22M14.72M18.97M
Cash, Cash Equivalents and Short-Term Investments4.54M4.17M6.67M11.64M16.38M
Total Debt542.23K239.37K332.26K357.96K476.31K
Total Liabilities1.63M1.27M1.46M1.70M1.92M
Stockholders Equity5.32M5.08M7.76M13.02M17.04M
Cash Flow
Free Cash Flow-2.35M-2.91M-4.97M-4.93M-4.33M
Operating Cash Flow-2.32M-2.81M-4.80M-4.52M-3.89M
Investing Cash Flow-132.93K-35.20K-118.20K-408.02K-441.45K
Financing Cash Flow2.82M351.00K-52.70K194.92K18.88M

Terragen Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
11.17
Positive
STOCH
37.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 11.17 is Positive, neither overbought nor oversold. The STOCH value of 37.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
50
Neutral
AU$24.92M-93.06%56.16%-53.89%
46
Neutral
AU$6.96M-292.54%63.44%
44
Neutral
AU$1.47B-5.90-41.17%4.21%-3.35%-41.14%
43
Neutral
AU$10.83M-16.63%-73.87%-11.11%
40
Underperform
AU$10.10M-58.72%-26.94%-4.08%
26
Underperform
AU$9.89M-146.25%-68.70%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:TGH
Terragen Holdings Ltd
0.02
0.00
0.00%
AU:ABX
ABx Group Limited
0.04
-0.01
-20.00%
AU:OLY
CropLogic Ltd.
0.10
0.06
150.00%
AU:CDT
Castle Minerals Limited
0.06
0.00
0.00%
AU:RLF
RLF AgTech Ltd
0.07
0.02
40.00%

Terragen Holdings Ltd Corporate Events

Terragen Holdings Expands Product Range and Secures US Patent
Jul 31, 2025

Terragen Holdings Limited has made significant strides in expanding its product offerings and market reach. The company launched a new dry format probiotic product for ruminants, gaining traction in the livestock market, particularly in beef and lamb feedlots. Additionally, Terragen secured a US patent for its microbial feed supplement, enhancing its position in the global animal probiotics market. The company also reported promising results from its Great Land Plus® trials on maize crops, showcasing improved yield and cost efficiency. Furthermore, Terragen has initiated a Next Gen Nitrogen Project in collaboration with Queensland University of Technology to expand its plant product offerings.

Terragen Secures US Patent for Microbial Feed Supplement
Jul 3, 2025

Terragen Holdings Limited has been granted a US patent for its microbial feed supplement, Terragen Probiotic for Ruminants™ and MYLO®, by the United States Patent and Trademark Office. This patent, valid until 2041, provides intellectual property protection in the US, a key market for Terragen, and supports the company’s efforts to secure regulatory approvals for product launch. The patent strengthens Terragen’s position in the global animal probiotics market, highlighting the innovative outcomes of its research and development program.

Terragen Holdings Announces CFO Resignation
Jun 4, 2025

Terragen Holdings Limited announced the resignation of its Chief Financial Officer and Company Secretary, Matthew Whyte, effective August 27, 2025, as he pursues other opportunities. The company is actively seeking his successor, and the transition is expected to impact its financial and administrative operations. The departure could influence Terragen’s strategic direction, given Whyte’s contributions to the company’s growth and development.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025